NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $369,039 | -1.2% | 3,623 | -2.2% | 0.08% | 0.0% |
Q2 2023 | $373,670 | +3.4% | 3,703 | -5.7% | 0.08% | -5.6% |
Q1 2023 | $361,376 | +0.7% | 3,928 | -0.7% | 0.09% | -8.2% |
Q4 2022 | $358,798 | +52.0% | 3,955 | +27.4% | 0.10% | +38.0% |
Q3 2022 | $236,000 | -9.9% | 3,105 | 0.0% | 0.07% | -9.0% |
Q2 2022 | $262,000 | -14.7% | 3,105 | -11.3% | 0.08% | -1.3% |
Q1 2022 | $307,000 | +0.3% | 3,501 | +0.2% | 0.08% | +8.2% |
Q4 2021 | $306,000 | +7.4% | 3,494 | +0.3% | 0.07% | -1.4% |
Q3 2021 | $285,000 | -10.4% | 3,485 | 0.0% | 0.07% | -12.9% |
Q2 2021 | $318,000 | +6.7% | 3,485 | 0.0% | 0.08% | -4.5% |
Q1 2021 | $298,000 | -10.5% | 3,485 | -1.1% | 0.09% | -19.1% |
Q4 2020 | $333,000 | +7.1% | 3,524 | -1.4% | 0.11% | -14.7% |
Q3 2020 | $311,000 | -2.5% | 3,575 | -2.1% | 0.13% | -8.5% |
Q2 2020 | $319,000 | +4.6% | 3,653 | -1.2% | 0.14% | -7.8% |
Q1 2020 | $305,000 | -10.0% | 3,696 | +3.3% | 0.15% | +10.9% |
Q4 2019 | $339,000 | +9.0% | 3,578 | 0.0% | 0.14% | +6.2% |
Q3 2019 | $311,000 | -4.9% | 3,578 | 0.0% | 0.13% | -11.6% |
Q2 2019 | $327,000 | -4.9% | 3,578 | 0.0% | 0.15% | -10.9% |
Q1 2019 | $344,000 | +12.1% | 3,578 | 0.0% | 0.16% | -5.2% |
Q4 2018 | $307,000 | +1.0% | 3,578 | +1.4% | 0.17% | +14.5% |
Q3 2018 | $304,000 | +7.8% | 3,529 | -5.4% | 0.15% | +0.7% |
Q2 2018 | $282,000 | -26.0% | 3,729 | -20.8% | 0.15% | -26.3% |
Q1 2018 | $381,000 | -3.5% | 4,708 | 0.0% | 0.20% | 0.0% |
Q4 2017 | $395,000 | -1.7% | 4,708 | +0.6% | 0.20% | -7.7% |
Q3 2017 | $402,000 | +0.8% | 4,682 | -2.1% | 0.22% | -7.1% |
Q2 2017 | $399,000 | +9.9% | 4,782 | -2.0% | 0.24% | -0.4% |
Q1 2017 | $363,000 | -2.4% | 4,882 | -4.4% | 0.24% | -10.4% |
Q4 2016 | $372,000 | -9.7% | 5,107 | -2.1% | 0.27% | -20.2% |
Q3 2016 | $412,000 | -3.7% | 5,214 | +0.4% | 0.34% | -10.2% |
Q2 2016 | $428,000 | +44.1% | 5,193 | +26.7% | 0.37% | +4.5% |
Q1 2016 | $297,000 | -15.9% | 4,098 | 0.0% | 0.36% | -20.8% |
Q4 2015 | $353,000 | -6.4% | 4,098 | 0.0% | 0.45% | -14.4% |
Q3 2015 | $377,000 | -6.5% | 4,098 | 0.0% | 0.53% | -2.2% |
Q2 2015 | $403,000 | -0.2% | 4,098 | 0.0% | 0.54% | +6.9% |
Q1 2015 | $404,000 | +6.3% | 4,098 | 0.0% | 0.50% | -12.8% |
Q4 2014 | $380,000 | -19.0% | 4,098 | -17.7% | 0.58% | -24.2% |
Q3 2014 | $469,000 | +4.0% | 4,978 | 0.0% | 0.76% | -1.0% |
Q2 2014 | $451,000 | +6.6% | 4,978 | 0.0% | 0.77% | +2.3% |
Q1 2014 | $423,000 | – | 4,978 | – | 0.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |